|
An event of pericardial effusion and thrombus was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all defined manufacturing specifications.There were no complaints associated with any other devices from the lot.Based on the available information, the cause for the reported thrombosis could not be confirmed.Reported pericardial effusion might be due to procedural complications (maneuvering of the guidewire or sheaths within the heart).An unexpected medical intervention was a result of case-specific circumstances, as a pericardiocentesis was performed.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|
|
It was reported that on (b)(6) 2026, a 28mm amplatzer amulet was chosen for implant using a 14f amulet delivery sheath.The transseptal puncture was performed at an inferior/posterior location, and the patient was in sinus rhythm at the time of the procedure.The patient¿s activated clotting time (act) was 270 seconds, no protamine or reversal agents were administered, and the left atrial pressure was 12 mmhg.The sheath was not in the patient longer than usual.During advancement of the system, the team experienced difficulty as they could not reach the left atrial appendage (laa) easily.A wire was positioned in the upper pulmonary vein, and at one point a wire was also placed in the left atrial appendage.There was one exchange of the delivery sheath.The amulet device underwent two partial recaptures, and during recapture, the device was retracted into the ball configuration.After these recapture attempts, a structure was observed near the device on tee imaging.The structure was described as a narrow elongated structure, and the team reported that it looked like a little thrombus, though it was not confirmed to be one.They stated that they did not know if it was a thrombus, only that a structure was visible.The physician indicated that the observed structure was not believed to be related to the device, and the structure was not visible again once the sheath and occluder were removed.Because of the observed structure, the team proceeded by replacing both the sheath and occluder and implanting a new 28 mm amplatzer amulet device using the 14f delivery sheath.The patient remained hemodynamically stable, and there was no clinically significant procedural delay.Six hours after completion of the procedure, the patient developed a circumferential pericardial effusion around the ventricle, measuring 1 cm, was identified.The effusion had not been present prior to the procedure.The physician did not consider the abbott device to be the cause, and there was no indication of cardiac tamponade at that time.A pericardial puncture was performed, and 400 ml of blood was withdrawn.
|